Alimera Sciences (ALIM) Misses Q2 EPS by 2c

Alimera Sciences (NASDAQ: ALIM) reported Q2 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $27 million versus the consensus estimate of $25.81 million.

For earnings history and earnings-related data on Alimera Sciences (ALIM) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• RBC Capital Upgrades LTC Properties (LTC) to Outperform
• Kepler Cheuvreux Upgrades Swissquote Group Holding SA (SQN:SW) to Buy